A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and the Drug-Drug Interaction Potential of Oral ACHN-383 and ACHN-789 in Healthy Subjects and to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ACHN-383 and ACHN-789 in Otherwise Healthy Subjects With Renal Impairment

Trial Profile

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and the Drug-Drug Interaction Potential of Oral ACHN-383 and ACHN-789 in Healthy Subjects and to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ACHN-383 and ACHN-789 in Otherwise Healthy Subjects With Renal Impairment

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs C-Scape (Primary)
  • Indications Urinary tract infections
  • Focus Adverse reactions
  • Sponsors Achaogen
  • Most Recent Events

    • 16 Nov 2017 Status changed from recruiting to completed.
    • 08 Nov 2017 According to an Achaogen media release, top line results are expected by the end of 2017.
    • 03 Aug 2017 According to an Achaogen media release, first patient is dosed in this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top